Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 4/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 1.00 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 1.00 |
| ▸ | ALB | P02768 | 3/20 | 1.00 |
| ▸ | GLI1 | P08151 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 1/20 | 1.00 |
| ▸ | NT5E | P21589 | 1/20 | 1.00 |
| ▸ | DPP4 | P27487 | 1/20 | 1.00 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 1.00 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 1.00 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.82 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.82 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.82 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.82 |
| ▸ | CES2 | O00748 | 2/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Betulinic Acid SCHEMBL14112364 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL13908717 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL14112012 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL7746410 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL10214465 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL9905925 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL23132693 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL13285621 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL22251646 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 | |
| Betulinic Acid SCHEMBL8283294 | 1.00 | RORC (1.00) | RORCPTPN1GPBAR1ALBGLI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11660306-B2 | Treatment of Rett syndrome | COLD SPRING HARBOR LABORATORY (US) | 2023-05-30 | — | — | US | disclosed |
| US-11660306-B2 | Treatment of Rett syndrome | COLD SPRING HARBOR LABORATORY (US) | 2023-05-30 | — | — | US | disclosed |
| US-11007269-B2 | P53 degradation inducing molecule and pharmaceutical composition | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2021-05-18 | — | — | US | disclosed |
| US-20200109163-A1 | CARBONATED BEVERAGE AND METHOD FOR CARBONATION ENHANCEMENT | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2020-04-09 | — | — | US | disclosed |
| US-20190314508-A1 | P53 DEGRADATION INDUCING MOLECULE AND PHARMACEUTICAL COMPOSITION | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2019-10-17 | — | — | US | disclosed |
| US-20190247408-A1 | TREATMENT OF RETT SYNDROME | COLD SPRING HARBOR LABORATORY (US) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190314508-A1 | P53 DEGRADATION INDUCING MOLECULE AND PHARMACEUTICAL COMPOSITION | TP53, TP53BP1, MDM2 | RORC 2948/4885PTPN1 1561/4885GPBAR1 3266/4885 |
| US-20200109163-A1 | CARBONATED BEVERAGE AND METHOD FOR CARBONATION ENHANCEMENT | CA9, CA2, CA4 | RORC 3514/4885PTPN1 4828/4885GPBAR1 1674/4885 |
| US-20190247408-A1 | TREATMENT OF RETT SYNDROME | MECP2, BDNF, NTRK2 | RORC 1467/4885PTPN1 4223/4885GPBAR1 1534/4885 |
| US-11660306-B2 | Treatment of Rett syndrome | MECP2, BDNF, NTRK2 | RORC 1467/4885PTPN1 4223/4885GPBAR1 1534/4885 |
| US-11007269-B2 | P53 degradation inducing molecule and pharmaceutical composition | TP53, TP53BP1, MDM2 | RORC 2948/4885PTPN1 1561/4885GPBAR1 3266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.